Antimicrobial susceptibility surveillance of recent isolates from ophthalmological infections to gatifloxacin and other antimicrobial drugs

Japanese Journal of Antibiotics

Volumn 58, Issue 1, 2005, Pages 45-49

  Matsuzaki, Kaoru ^a   Koyama, Hideaki ^a   Watabe, Emiko ^a   Hasegawa, Miyuki ^a   Sato, Yumie ^a   Kobayashi, Intetsu ^a  

^a LSI MEDIENCE CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFMENOXIME; EYE DROPS; GATIFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ENTEROCOCCUS FAECALIS; EYE INFECTION; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPPORTUNISTIC INFECTION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; EYE INFECTIONS, BACTERIAL; FLUOROQUINOLONES; GRAM-POSITIVE BACTERIA; HUMANS; OFLOXACIN; QUINOLONES;

EID: 15544387733     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. HOSAKA, M.; T. YASUE, H. FUKUDA, et al.: In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Antimicrob. Agents Chemother. 36: 2108-2117, 1992
2. KOWALSKI, R. P.; D. K. DHALIWAL, L. M. KARENCHAK, et al.: Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am. J. Ophthalmol. 136: 500-505, 2003
3. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing; fourteenth informational supplement M100-S14. Wayne, PA, 2004
4. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-sixth edition. M7-A6. Wayne, PA, 2003
5. National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard-fifth edition. M11-A5. Wayne, PA, 2001
6. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing of anaerobic bacteria; informational supplement M100-S13. Wayne, PA, 2003
7. TOKUE, Y.; K. SUGANO, D. SAITO, et al.: Detection of novel mutations in the gyr A gene of Staphylococcus aureus by nonradioisotopinic single-strand conformation polymorphism analysis and direct DNA sequencing. Antimicrob. Agents Chemother. 38: 428-431, 1994
8. NAKANISHI, N.; S. YOSHIDA, H. WAKEBE, et al.: Mechanisms of clinical resistance to fluoroquinolones in Enterococcus faecalis. Antimicrob. Agents Chemother. 35: 1053-1059, 1991